Internal Control · 2024
In this section9 topics
- Internal Control — Board Opinion1 item
- Adequacy & Appropriateness of the Internal Control System1 item
- Internal Control Deficiencies1 item
- Audit Committee & Auditor Observations3 items
- Opinion on the Head of Internal Audit2 items
- Appointment, Discharge & Transfer of the Head of Internal Audit2 items
- Related Party Transactions1 item
- Counterparties & Transactions3 items
- Policy & Future Trends2 items
Internal Control — Board Opinion
Summary of the Board's Opinion on Internal Control
The Board of Directors and management are directly responsible for establishing and maintaining an effective internal control system. The Company has a policy that emphasizes the importance of internal control continuously, aiming to have sufficient and appropriate internal control systems in place to enhance efficiency and effectiveness in operations, resource utilization, and asset protection. The Company maintains accurate and reliable accounting systems and financial reporting, complies with relevant laws, regulations, and guidelines applicable to its business operations, and strictly adheres to them. Therefore, the Board of Directors has assigned the Audit Committee the authority and responsibility to review and ensure the Company’s financial statements are accurate and adequate, review the internal control system and internal audit practices to be appropriate and effective, and review compliance with securities and stock market regulations or laws pertaining to the Company’s operations. The Audit Committee performs its duties in accordance with the assignment of the Board of Directors and the charter of the Audit Committee, with due care, independence, and straightforwardness, without limitations in accessing information, and emphasizes good corporate governance following the guidelines of the Stock Exchange of Thailand.
The Company has an internal control and risk management system which complies with The Committee of Sponsoring Organizations of the Treadway Commission - Enterprise risk management (COSO-ERM). This framework is related to the Company’s business operations and management processes. The Company’s board of directors has inquired various matters in accordance with the internal control system's adequacy assessment and the audit committee's reports.
Adequacy & Appropriateness of the Internal Control System
Internal Control Framework Used
| Framework | Detail |
|---|---|
| COSO - Enterprise Risk Management Framework (ERM) | Currently, the Company has appointed Thirty-Four Audit Office Co., Ltd. as the internal auditor of the Company. The internal auditor is to assess the facts through interviews with management and personnel of each department, observe the actual operations in certain aspects of the various departments related to the Company’s business, review the work procedures, operational documents and important accounting documents and financial statements of the Company as well as audit the Company’s key activities in main cycle regarding risks and various control points to draw conclusions about the effectiveness of the current internal control system. There are conclusions from assessing the Company’s internal control system in various areas of the five components: 1) Internal Control within the Organization 2) Risk Assessment 3) Operational Control 4) Information Systems and Data Communication 5) Monitoring Systems In addition, the external auditor of the Company, DIA International Audit Co., Ltd., audited the financial statements for the year ended December 31, 2024 and no significant observations on material weaknesses in the Company’s internal control system related to finance and accounting. The management is confident that the Company’s internal control system is sufficiently adequate to prevent and detect any potential damage from unauthorized or inadequate actions. In 2024, the Audit Committee expressed opinion that the Company has an adequate and appropriate internal control system, as stated in Audit Committee Report. Furthermore, the Company’s auditors, DIA International Audit Co., Ltd, evaluated the effectiveness of the Company’s internal control system and reported no significant observations on material weaknesses affecting the financial statements. |
Internal Control Deficiencies
Number of Deficiencies
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of internal control system deficiencies (cases) | 0 | 0 | 0 |
Audit Committee & Auditor Observations
Introduction
At the Board of Directors Meeting No. 1/2025, held on February 20, 2024, the board evaluated the Company’s internal control system using the "Assessment of the Adequacy of Internal Control System" form provided by the Securities and Exchange Commission (SEC) in accordance with the framework of the Committee of Sponsoring Organizations of the Treadway Commission (COSO), which had been revised in May 2013. The Board of Directors presented it to the audit committee, who determined that the Company has an adequate and appropriate internal control system to conduct its business and achieve the objectives of internal control in terms of effectiveness and efficiency of operations, as well as proper control of the Company’s resources. It is also confirmed that the Company’s financial reports are accurate, reliable, and timely, and that the Company complies with all relevant laws, regulations, and policies, including those set by external regulatory organizations. The Board of Directors expressed the opinion that the Company’s internal control system for the year 2024 is sufficiently effective and in line with the internal control framework.
The management team is confident that the Company’s internal control system is sufficiently robust to prevent and mitigate any potential damage arising from unauthorized or insufficient actions.
Audit Committee's Opinion Differs from the Board's
No
Auditor Has Observations on Internal Control
No
Opinion on the Head of Internal Audit
Head of Internal Audit
3160
Audit Committee's Opinion on the Head of Internal Audit
Company
Appointment, Discharge & Transfer of the Head of Internal Audit
Requires Audit Committee Approval
Yes
Description
Company
Related Party Transactions
Has Related Party Transactions
Yes
Counterparties & Transactions
Monetary Unit
1
Counterparties with Potential Conflicts
| Name | Person / Juristic Person | Nature of Relationship | As of Date (YYYY-MM-DD) |
|---|---|---|---|
| Dr. Wattana Chaiwat | Person | - Major shareholders, holding 50.54% of shares. - Director - Chairman of the Board of Directors - Chief Executive Officer (CEO) | 2024-12-31T00:00 |
| Miss Siriluck Tangborirak | Person | - Holding 0.03% of shares. - Director - Executive Director - Assistant Chief Executive Officer of Business Development | 2024-12-31T00:00 |
Transactions by Counterparty
| Transactions |
|---|
| 825692.91 · Necessity: This transaction is occurred because LDC needs a tenant for the highest value and benefits in utilizing the space. · Description: Open Amazon Cafe at Srinakarin branch on September 25, 2017. · As of yesteryear: 737534.08 · Nature of transaction: Rent or let the rent of real estate for a period not exceeding 3 years and without general trading conditions with Love Hand Group Co., Ltd. LDC made a sub-lease agreement with Love Hand Group Co., Ltd., a juristic person with Dr. Wattana Chaiwat as a director with authority to control the business · Audit committee opinion: The Audit Committee has considered the related transactions between the Company and persons who may have conflicts of interest, or potential conflicts of interest in the future, as stated by the Securities and Exchange Commission. The Committee has expressed the opinion that the aforementioned transactions are reasonable, complies with fair commercial conditions, and are treated in the same manner as persons or unrelated enterprises. There is no transfer of benefits between the Company and others. · As of year before yesteryear: 820650.02 · 358399.79 · Necessity: This transaction is occurred because LDC needs a tenant for the highest value and benefits in utilizing the space. · Description: Operating an accommoddations business at Chiang Mai branch on June 1, 2027. · As of yesteryear: 0.0 · Nature of transaction: Rent or let the rent of real estate for a period not exceeding 3 years and without general trading conditions with Sleep Owl Co., Ltd. LDC made a sub-lease agreement with Sleep Owl Co., Ltd., a juristic person with Miss Siriluck Tangborirak who is a director of the Company, is a director of the Lessee ("Sleep Owl") and Dr. Wattana Chaiwat, who is a director of the Company, the Chief Executive Officer, and a major shareholder with controlling power in the Company. · Audit committee opinion: The Audit Committee has considered the related transactions between the Company and persons who may have conflicts of interest, or potential conflicts of interest in the future, as stated by the Securities and Exchange Commission. The Committee has expressed the opinion that the aforementioned transactions are reasonable, complies with fair commercial conditions, and are treated in the same manner as persons or unrelated enterprises. There is no transfer of benefits between the Company and others. · As of year before yesteryear: 0.0 · 450000.0 · Necessity: The building is located on the company's leased land, where the lease will expire on December 31, 2024, and the tenant does not wish to renew the lease. Currently, the building is leased as an office by a third party, who is also a tenant of a part of the company's space, and the third party wishes to lease the entire space to the company. The company sees an opportunity to increase revenue from space rental by utilizing the vacant space to generate returns. · Description: - Building Information: 1-storey multi-purpose building (no obligation) - Size of space: 72 sq.m. - Buying and Selling Price: 450,000 Baht · As of yesteryear: 0.0 · Nature of transaction: Acquisition of an asset, which is a single-story multipurpose building located adjacent to the LDC Dental Clinic, Lat phrao Branch from Lovehand Group Co., Ltd. Dr. Wattana Chaiwat, a Director, Chief Executive Officer and a major shareholder with controlling power in the company. LDC Dental Public Company Limited (the "Buyer") is a director and is a major shareholder with controlling power 100% of Lovehand Group Co., Ltd. (the "Seller") · Audit committee opinion: The Board of Directors (excluding directors with vested interests in this transaction) has considered that and deemed that this connected transaction is appropriate and beneficial to the Company, the property is a multi-purpose building that can be used continuously by leasing additional space to generate sustainable income from the assets. in addition, the building has existing tenants who are operating in a manner that is in line with the Company's business interests and already generate rental income for the seller, so it is possible to maintain the income from such tenants comtinuously. The Board of Directors considers the price to be reasonable and fair, as it has been assessed based on a market price comparison. Additionally, it has passed the moderation from the Audit Committee, Therefore, it is believed that this transaction will bring benefits to the Company. · As of year before yesteryear: 0.0 |
| 358399.79 · Necessity: This transaction is occurred because LDC needs a tenant for the highest value and benefits in utilizing the space. · Description: Operating an accommoddations business at Chiang Mai branch on June 1, 2027. · As of yesteryear: 0.0 · Nature of transaction: Rent or let the rent of real estate for a period not exceeding 3 years and without general trading conditions with Sleep Owl Co., Ltd. LDC made a sub-lease agreement with Sleep Owl Co., Ltd., a juristic person with Miss Siriluck Tangborirak who is a director of the Company, is a director of the Lessee ("Sleep Owl") and Dr. Wattana Chaiwat, who is a director of the Company, the Chief Executive Officer, and a major shareholder with controlling power in the Company. · Audit committee opinion: The Audit Committee has considered the related transactions between the Company and persons who may have conflicts of interest, or potential conflicts of interest in the future, as stated by the Securities and Exchange Commission. The Committee has expressed the opinion that the aforementioned transactions are reasonable, complies with fair commercial conditions, and are treated in the same manner as persons or unrelated enterprises. There is no transfer of benefits between the Company and others. · As of year before yesteryear: 0.0 |
Policy & Future Trends
Policy, Measures & Approval Process
In cases there are transactions between the Company and related parties, persons with conflicts of interest, or potential conflicts of interest in the future, which are commercial agreements similar to those that a prudent person would engage in with unrelated parties in similar situations, having the authority to negotiate trading terms without the influence of being a director, executive, or related parties. The transactions are subject to normal commercial conditions or market prices, under reasonable and justifiable conditions, and are subject to scrutiny to ensure that no transfer of benefits occurs. The Company’s management is able to conduct transactions in a normal manner, in accordance with the principles approved by the Board of Directors, and provides quarterly reports to the Audit Committee for their acknowledgment.
In case there are related transactions that are not ordinary commercial transactions, the Company will require the opinion of Audit Committee regarding the necessity and appropriateness of such transactions. If Audit Committee does not have expertise in evaluating the transactions that may occur, the Company will consider obtaining an independent appraiser, a specialized expert, or an auditor to provide opinions on the said transactions to Audit Committee to assist in making decisions and providing opinions to the Board of Directors or shareholders, as the case may be, for approval of the transactions before proceeding further actions. The Company will disclose these related transactions in the notes to financial statements. However, the approval of such related transactions will be in accordance with securities and capital market laws and regulations, as well as the rules, notifications, orders, or provisions of the Stock Exchange of Thailand. Those who may have conflicts of interest or may be affected by the transactions will not have the right to vote or participate in the decision-making process regarding such transactions.
Future Trends in Related Party Transactions
In the future, if the Company needs to engage in transactions with persons who may have conflicts of interest with the Company, the Company will establish conditions that align with the nature of normal business operations and market prices, which can be benchmarked against conditions or prices that occur in similar transactions with external parties in the same industry. In such cases, the Audit Committee will provide opinions on the prices, remuneration rates, as well as the necessity and appropriateness of the transactions. If the Audit Committee does not have the expertise to evaluate such transactions, the Company may seek opinions from independent appraisers, specialized experts, or the Company’s auditor to assist the Auditing Committee in making decisions and providing opinions to the Company’s Board of Directors or shareholders, as the case may be.
For related transactions that may occur in the future, directors must comply with various regulations that have been established and directors are not entitled to approve any transactions in which they or persons who may have conflicts of interest in any other manner with the Company. Such transactions must be disclosed to the Board of Directors for consideration.
Furthermore, it is anticipated that future transactions may involve guarantees on behalf of the Company on behalf of ordinary person and without any remuneration. Loans provided to the Company with interest rates based on market rates.
Investor Protection Measures
To protect investors, in the event of any related transactions between the Company and persons that may have conflicts of interest, or potential conflicts of interest in the future, the Company will arrange for the presentation of such transactions through meetings of Board of Directors attended by the Audit Committee. This is to ensure that the related transactions comply with securities and exchange law, as well as regulations, rules, notifications, and provisions of the Stock Exchange of Thailand, including compliance with disclosure requirements for related transactions and acquisitions or disposals.

